Project Grant R24AI191865
Award Date
6/18/25
Completion Date
5/31/30
Dollars Obligated
$773K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $623,243 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Washington. The grant, titled "ACCELERATING PUBLIC HEALTH IMPACT THROUGH THE UNIVERSITY OF WASHINGTON/NASTAD RESEARCH ALLIANCE IN IMPLEMENTATION SCIENCE TO END HIV (RAISE) REGIONAL CONSULTATIVE HUB", aims to enhance the impact of the Ending the HIV Epidemic (EHE) initiative through implementation...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $820,845 to New York University School of Medicine to conduct research aimed at improving HIV outcomes across diverse settings and subgroups in the U.S. HIV epidemic. The research will use mathematical modeling to simulate alternative ways to distribute resources across interventions, settings, and target...
This federal Project Grant award, with a total funding amount of $126,387.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will support Dr. Lauren Zalla's research at the Johns Hopkins Bloomberg School of Public Health, focused on studying the role of the urban environment as a modifiable social determinant of health among people living with HIV. The study aims to: 1) describe...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund the development of a novel suite of local-level syphilis epidemiologic and economic models (LSEEM) across 40 U.S. cities with the highest syphilis diagnosis rates. The $1,550,917 award, spanning from July 2024 to May 2029, aims to assess the potential impact of scaling up existing syphilis control...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $681,278 to The Johns Hopkins University to conduct research on the HIV latent reservoir and the mechanisms driving clonal proliferation and persistence of infected cells in people living with HIV on antiretroviral therapy. The key objectives are to: 1) Fully characterize the intact and defective provirus clonality...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,356,188 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University to characterize the HIV-1 proviral pool in neonates and infants receiving very early and enhanced early antiretroviral therapy (ART) and broadly neutralizing antibodies (bNAbs) towards achieving ART-free remission. The project aims to quantify and analyze the intact proviral reservoir,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,279,005 to The Johns Hopkins University from July 2024 through May 2029. The research aims to uncover the mechanisms underlying hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) transcriptional silencing, which could lead to a functional cure for HBV, especially in the context of HBV/HIV...
This $197,366 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to understand the mechanisms behind the human immune system's natural restriction of a specific subset of the HIV virus. The key objectives are to: 1) Characterize the molecular mechanisms driving the restriction of X4-tropic HIV replication in the presence of R5-tropic virus, and 2) Determine the...
This Project Grant award of $445,500 from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) under the AIDS Education and Training Centers (AETC) Program (CFDA 93.145) supports The Johns Hopkins University in Baltimore, Maryland to develop and enhance the capacity of healthcare providers to deliver high-quality HIV prevention, care, and treatment services. The award, effective September 1, 2024 through August 31, 2025, will fund a range of...
This federal Project Grant award of $696,828, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural basis of HIV-1 cap hypermethylation and its linkage to viral post-transcriptional control and modulation of host innate immune signaling. Key objectives include elucidating the role of the HIV-1 Rev/RRE regulatory system in cap hypermethylation, and how...